BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23669141)

  • 1. Seeking for a way to revive erythropoietin production in chronic kidney disease.
    Chang YT; Pan SY; Lin SL
    J Formos Med Assoc; 2013 Nov; 112(11):657-8. PubMed ID: 23669141
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenesis and treatment of anemia in chronic kidney disease].
    Nangaku M
    Rinsho Ketsueki; 2017; 58(10):1860-1863. PubMed ID: 28978825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathophysiology of anemia in chronic kidney diseases: A review.
    Zadrazil J; Horak P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2015 Jun; 159(2):197-202. PubMed ID: 24401900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Regulation of erythropoiesis and pathogenesis of anemia].
    Komatsu N
    Nihon Rinsho; 2008 Mar; 66(3):420-2. PubMed ID: 18326311
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment with erythropoiesis-stimulating agents in chronic kidney disease patients with cancer.
    Hazzan AD; Shah HH; Hong S; Sakhiya V; Wanchoo R; Fishbane S
    Kidney Int; 2014 Jul; 86(1):34-9. PubMed ID: 24402094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogenesis of renal anemia.
    Nangaku M; Eckardt KU
    Semin Nephrol; 2006 Jul; 26(4):261-8. PubMed ID: 16949463
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anemia: From Basic Knowledge to Up-to-Date Treatment. Topic: VII. Anemia in chronic kidney disease].
    Tsuruya K; Hirakata H
    Nihon Naika Gakkai Zasshi; 2015 Jul; 104(7):1414-24. PubMed ID: 26513961
    [No Abstract]   [Full Text] [Related]  

  • 8. DNA methyltransferase inhibition restores erythropoietin production in fibrotic murine kidneys.
    Chang YT; Yang CC; Pan SY; Chou YH; Chang FC; Lai CF; Tsai MH; Hsu HL; Lin CH; Chiang WC; Wu MS; Chu TS; Chen YM; Lin SL
    J Clin Invest; 2016 Feb; 126(2):721-31. PubMed ID: 26731474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Renal anemia: from incurable to curable.
    Sato Y; Yanagita M
    Am J Physiol Renal Physiol; 2013 Nov; 305(9):F1239-48. PubMed ID: 23884144
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Influence of tumor necrosis factor-alpha and interferon-gamma on erythropoietin production and erythropoiesis in cancer patients with anemia].
    Wang W; Zhang MH; Yu Y; Xu CG
    Zhonghua Xue Ye Xue Za Zhi; 2007 Oct; 28(10):681-4. PubMed ID: 18399174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythropoietin production by the kidney.
    Koury ST; Koury MJ
    Semin Nephrol; 1993 Jan; 13(1):78-86. PubMed ID: 8434189
    [No Abstract]   [Full Text] [Related]  

  • 12. [Renal insufficiency and erythropoietin].
    Takaku F
    Nihon Rinsho; 1974 Mar; 32(3):528-34. PubMed ID: 4603797
    [No Abstract]   [Full Text] [Related]  

  • 13. Erythropoietin: oxygen-dependent control of erythropoiesis and its failure in renal disease.
    Eckardt KU
    Nephron; 1994; 67(1):7-23. PubMed ID: 8052371
    [No Abstract]   [Full Text] [Related]  

  • 14. Interrelationship between erythropoietin and erythropoiesis: insights from renal transplantation.
    Lee DB
    Am J Kidney Dis; 1991 Oct; 18(4 Suppl 1):54-6. PubMed ID: 1928080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythropoietin, the biology of erythropoiesis and epoetin alfa. An overview.
    Bieber E
    J Reprod Med; 2001 May; 46(5 Suppl):521-30. PubMed ID: 11396386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic kidney disease-associated anemia: new remedies.
    Del Vecchio L; Cavalli A; Tucci B; Locatelli F
    Curr Opin Investig Drugs; 2010 Sep; 11(9):1030-8. PubMed ID: 20730698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical relevance of anemia treatment in patients with chronic kidney disease].
    Vuksanović-Mikulicić S; Mikolasević I; Jelić I; Bubić I; Sladoje-Martinović B; Racki S
    Acta Med Croatica; 2012 Jul; 66(3):193-202. PubMed ID: 23441533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison between Long- and Short-Acting Erythropoiesis-Stimulating Agents in the Period Required for Haemoglobin Stabilisation in Treatment of Anaemia in Patients with Chronic Kidney Disease.
    Hayashi T; Nagamatsu T; Matsushita A; Mizuno T; Nishibe S; Noguchi A; Kato R; Toda T; Tanaka J; Takahashi H; Hayashi H; Yuzawa Y; Yamada S
    Biol Pharm Bull; 2015; 38(5):740-5. PubMed ID: 25740003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The kidney and erythropoiesis.
    Stohlman F
    N Engl J Med; 1968 Dec; 279(26):1437-9. PubMed ID: 5722918
    [No Abstract]   [Full Text] [Related]  

  • 20. Down-Regulation of Cardiac Erythropoietin Receptor and its Downstream Activated Signal Transducer Phospho-STAT-5 in a Rat Model of Chronic Kidney Disease.
    Hertzberg-Bigelman E; Barashi R; Levy R; Cohen L; Ben-Shoshan J; Keren G; Entin-Meer M
    Isr Med Assoc J; 2016 Jun; 18(6):326-30. PubMed ID: 27468524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.